A Study to Evaluate the Influence of Diet on GI Health
NCT04783142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-05-15
Summary
The purpose of this study is to understand the potential of protein and psyllium fiber to manipulate gut microbial densities, intestinal permeability, and inflammation in humans.
Conditions
- Healthy
Interventions
- OTHER
-
High-fiber, low-protein diet
Diet will consist of at least 15g fiber above baseline and less than 10% of calories from protein.
- OTHER
-
Low-fiber, high-protein diet
Diet will consist of less than 15g fiber and greater than 18% of calories from protein
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Purna C. Kashyap, MBBS · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-06-11
- Primary Completion
- 2023-03-27
- Completion
- 2023-03-27
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Variation of the Intestinal Microbiota and the Integrity of the Intestinal Barrier in Patients With M.D.R. Germ-induced Pneumonia Undergoing Enteral Nutrition
NCT06485791 ·Status: NOT_YET_RECRUITING
-
The Impact of Food on Gut Microbiome Composition - a Clinical Trial Determining the Influence of Diet in Gut Microbiome Colonisation and Host Health
NCT05986955 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT04067440 ·Status: COMPLETED
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia
NCT02127749 ·Status: COMPLETED ·Phase: NA
-
Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
NCT05465629 ·Status: RECRUITING ·Phase: NA
-
FMT in Uncomplicated Diverticulitis
NCT05373784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
NCT05873231 ·Status: RECRUITING
-
Plant Based Diet, Ethnicity, and the Gut Microbiome
NCT03314194 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function
NCT04486482 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Outpatients in an Gut Microbiota Clinic
NCT06845527 ·Status: RECRUITING
-
Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
NCT05930197 ·Status: COMPLETED ·Phase: PHASE1
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
NCT03005379 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin®
NCT05800704 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT05107245 ·Status: COMPLETED
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
Intestinal Microbiome and Chemotherapy
NCT02875249 ·Status: COMPLETED
-
Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy
NCT04171466 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Stool Microbiome Using HyGIeaCare Prep
NCT04264923 ·Status: COMPLETED ·Phase: NA
-
Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics
NCT03862079 ·Status: WITHDRAWN ·Phase: PHASE2
-
Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum
NCT02343328 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics
NCT07251127 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota
NCT02534272 ·Status: TERMINATED